← Back to headlines
SAB Biotherapeutics Prices $85M Stock Offering, Shares Slip
SAB Biotherapeutics announced the pricing of an $85 million stock offering, leading to a 5% slip in its share price.
Sources
Showing 0 of 0 sources
SAB Biotherapeutics announced the pricing of an $85 million stock offering, leading to a 5% slip in its share price.
